Now enrolling for a clinical research trial to help effectiveness of an investigational GLP-1 injectable therapy vs a placebo on lung function, improvement of COPD symptoms and reduce overall COPD exacerbations in overweight adults with moderate or severe COPD.

​

Qualifications

• 40-75 years of age

• Diagnosis of moderate to severe COPD

• Current or former smoker

• BMI >25

• No diagnosis of asthma 

• No Type 1 Diabetes

• Additional criteria may apply​

​

What to Expect

• 68-week study commitment Kirkland, WA

• Compensation up to $4,500

• Your study information and results are private and confidential

To participate please fill out the form below to be contacted by a member of our clinical research team.